BioRestorative Therapies Taps Aesthetics Veteran to Lead Biocosmeceuticals Push
Event summary
- BioRestorative Therapies appointed Zachary Smith as Vice President of its Biocosmeceuticals Division on June 18, 2026.
- Smith brings 16 years of experience in medical aesthetics, biologics, and capital equipment markets.
- He previously served as Area Vice President at Cartessa Aesthetics, leading high-performing territories.
- Smith will focus on expanding sales channels, strategic partnerships, and revenue growth in regenerative aesthetics.
The big picture
BioRestorative Therapies is doubling down on its biocosmeceuticals division, a strategic pivot from its core focus on stem cell-based therapies for disc/spine and metabolic disorders. The appointment of Zachary Smith signals an aggressive push into the high-growth regenerative aesthetics market, where BioRestorative aims to differentiate itself with cell-based secretome products. The move comes as the company seeks to diversify its revenue streams amid ongoing clinical trials for its disc/spine and metabolic programs.
What we're watching
- Commercial Execution
- How Smith's track record in territory expansion will translate to BioRestorative's biocosmeceutical platform.
- Market Penetration
- Whether BioRestorative can sustain growth in the competitive regenerative aesthetics market.
- Strategic Partnerships
- The pace at which BioRestorative forms new partnerships to bolster its commercial reach.
Related topics